GlassScriptPhysician profile
Aldo H Martinez Fleites
NPI 1588896120
$2,230.45
in general payments reported to CMS, 2019-2025
24 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $325 · 2021: $639 · 2022: $365 · 2023: $315 · 2024: $203 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $479.55 | 2020-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $281.08 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $280.46 | 2019-2025 | Eliquis, Camzyos |
| Medtronic, INC. | $221.53 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $159.83 | 2020-2024 | Farxiga |
| Medtronic Vascular, INC. | $139.39 | 2020 | |
| Osprey Medical INC | $136.39 | 2021 | |
| Pfizer INC. | $89.90 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $75.67 | 2021-2022 | |
| Abbott Laboratories | $67.05 | 2022-2023 | Aveir |
| Kestra Medical Technology Services, INC. | $53.49 | 2024-2025 | Assure Wcd |
| Amarin Pharma, INC. | $53.13 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $44.56 | 2024 | Arcalyst |
| Glaxosmithkline, LLC. | $36.23 | 2021 | |
| Edwards Lifesciences Corporation | $25.34 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.94 | 2019 | |
| Abbvie INC. | $19.44 | 2022 | |
| Novo Nordisk INC | $17.93 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.78 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.76 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aldo Martinez Fleites listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.